Showing 1 - 3 results of 3 for search 'Madlaina Costa‐Scharplatz', query time: 0.02s Refine Results
  1. 1
    Indacaterol/glycopyrronium is cost-effective compared to salmeterol/fluticasone in COPD: FLAME-based modelling in a Swedish population

    Indacaterol/glycopyrronium is cost-effective compared to salmeterol/fluticasone in COPD: FLAME-based modelling in a Swedish population by Leif Bjermer, Job F. M. van Boven, Madlaina Costa-Scharplatz, Dorothy L. Keininger, Florian S. Gutzwiller, Karin Lisspers, Ronan Mahon, Petter Olsson, Nicolas Roche

    Published 2017-12-01
    Get full text
    Article
  2. 2
    Implementation of sacubitril/valsartan in Sweden: clinical characteristics, titration patterns, and determinants

    Implementation of sacubitril/valsartan in Sweden: clinical characteristics, titration patterns, and determinants by Michael Fu, Ola Vedin, Bodil Svennblad, Erik Lampa, Daniel Johansson, Ulf Dahlström, Krister Lindmark, Peter Vasko, Anna Lundberg, Madlaina Costa‐Scharplatz, Lars H. Lund

    Published 2020-12-01
    Get full text
    Article
  3. 3
    Recurrent heart failure hospitalizations increase the risk of cardiovascular and all‐cause mortality in patients with heart failure in Sweden: a real‐world study

    Recurrent heart failure hospitalizations increase the risk of cardiovascular and all‐cause mortality in patients with heart failure in Sweden: a real‐world study by Krister Lindmark, Kurt Boman, Jan Stålhammar, Mona Olofsson, Raquel Lahoz, Rachel Studer, Clare Proudfoot, Stefano Corda, Ana Filipa Fonseca, Madlaina Costa‐Scharplatz, Aaron Levine, Michael Törnblom, Anna Castelo‐Branco, Eleni Kopsida, Gerhard Wikström

    Published 2021-06-01
    Get full text
    Article

Search Tools: